Health & Wellness
The implication, of course, is that if you deny any part of conventional AIDS theories, you're as bad as a Nazi war criminal. It's a curious comparison, especially given that the origins of the modern pharmaceutical industry are found precisely in the Nazi regime where pharmaceutical scientists routinely conducted medical experiments on Jewish prisoners. As a fascinating matter of historical fact, the Chairman of Bayer in the 1950's (yes, the same Bayer that makes Bayer Aspirin) was Dr. Fritz ter Meer, a convicted war criminal, who after committing crimes against humanity was sentenced to seven years in prison at the Nuremberg war trials.
The pharmaceutical industry operating today is largely a cabal of unindicted criminals who are guilty of crimes against humanity, and one of their favorite methods of multiplying their profits is to push a disease, then sell a vaccine they claim "treats" the disease. It's the same old scam, whether we're talking about cervical cancer, swine flu or even AIDS.
Deane Berg, 52, applied talc-based body powder to her perineum each day after showering from 1975 to 2007, she says in a federal lawsuit filed last week. She contracted ovarian cancer in 2006.
Berg maintains that talc caused her cancer and that the companies selling the mineral knew there was a risk but failed to warn the public.
"I feel like women have been kept in the dark about a known hazard," said R. Allen Smith, Berg's lawyer. "It's the classic definition of why we need product liability lawsuits."
Listen in on aspartame hearings in 1976 between Senator Ted Kennedy and FDA Commissioner Alexander Schmidt at the Senate Subcommittee on Labor and Public Health:
Commissioner Schmidt: "Today I would like to report to you the final results of the Food and Drug Administration's detailed investigation of animal studies performed by Searle."Yet a year later look what happened!
Senator Kennedy: "Is this the first time, to your knowledge, that such a problem has been uncovered of this magnitude by the Food and Drug Administration?"
Dr. Schmidt: "It is certainly the first time that such an extensive and detailed examination of this kind has taken place. We have never before conducted such an examination as we did at Searle. From time to time, we have been aware of isolated problems, but we were not aware of the extent of the problem in one pharmaceutical house."
Senator Kennedy: "The extensive nature of the almost unbelievable range of abuses discovered by the FDA on several major Searle products is profoundly disturbing."
$2 million US dollar verdict against Bayer confirms company's liability for an uncontrollable technology
Greenpeace welcomes the United States federal jury ruling on 4 December 2009 that Bayer CropScience LP must pay $2 million US dollars to two Missouri farmers after their rice crop was contaminated with an experimental variety of rice that the company was testing in 2006.
Published in Nature Neuroscience and the Proceedings of the National Academy of Sciences, the two studies from the laboratory of Murray Sherman both demonstrate the important role of the thalamus in shaping what humans see, hear and feel.
"The thalamus really hasn't been a part of people's thinking of how cortex functions," said Sherman, professor and chairman of neurobiology at the University of Chicago Medical Center. "It's viewed as a way to get information to cortex in the first place and then its role is done. But the hope is these kinds of demonstrations will start putting the thalamus on the map."

Researchers are trying to figure out what happens in the brain when children have post-traumatic stress symptoms.
A new study published in the Journal of Pediatric Psychology found that children with symptoms of post-traumatic stress had poor function of the hippocampus, a part of the brain that stores and retrieves memories.
This is the first study to use functional magnetic resonance imaging, or fMRI, to look at the function of the hippocampus in youth with symptoms of post-traumatic stress, researchers said. The findings are in line with what has been previously found in adults.
The study was led by Dr. Victor Carrion, and the senior author was Dr. Allan Reiss, both at the Center for Interdisciplinary Brain Sciences Research at Stanford University School of Medicine.
The intersection of those three people led to a long series of experiments with more than 200 smart and frisky laboratory mice that revealed that learning new tasks can permanently alter the brain's nerve cells in animals, and perhaps in humans.
In a recent visit to her lab among the towering redwoods on the Santa Cruz campus, Zuo explained that her lab mice have shown her and her research team that in learning a new task, the connections between specific cells in the brain are swiftly rewired, and that those fresh connections can become permanent - even after the mice learn even newer tasks.
Much the same must be true in humans, she concluded.
The study, published today in the journal Neuron, was lauded by the director of the National Institute of Mental Health, Dr. Thomas R. Insel. The NIMH funded the research.
"We have known that behavioral training can enhance brain function," Insel said in a news release. "The exciting breakthrough here is detecting changes in brain connectivity with behavioral treatment. This finding with reading deficits suggests an exciting new approach to be tested in the treatment of mental disorders, which increasingly appear to be due to problems in specific brain circuits."
Inpatient medication errors represent an important patient safety issue, with one review finding some degree of error in almost one in every five medication doses. The patient, as the last link in the medication administration chain, represents the final individual capable of preventing an incorrect medication administration. Researchers from the University of Colorado Denver School of Medicine conducted a pilot study to assess patient awareness of their in-hospital medications and surveyed attitudes towards increased patient knowledge of hospital medications.
"Overall, patients in the study were able to name fewer than half of their hospital medications," said lead researcher Ethan Cumbler, M.D., Assistant Professor of Medicine at the University of Colorado Denver. "Our findings are particularly striking in that we found significant deficits in patient understanding of their hospital medications even among patients who believed they knew, or desired to know, what is being prescribed to them in the hospital."







